Comparison of dimethyl fumarate and interferon outcomes in an MS cohort

BACKGROUND: To compare the effectiveness of dimethyl fumarate (DMF) with subcutaneous interferon beta-1a (IFNβ-1a) in controlling disease activity in patients with relapsing–remitting Multiple Sclerosis (MS). METHODS: Clinical and imaging data from patients treated with either IFNβ-1a or DMF for at...

Descripción completa

Detalles Bibliográficos
Autores principales: Sattarnezhad, Neda, Healy, Brian C., Baharnoori, Moogeh, Diaz-Cruz, Camilo, Stankiewicz, James, Weiner, Howard L., Chitnis, Tanuja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277810/
https://www.ncbi.nlm.nih.gov/pubmed/35820822
http://dx.doi.org/10.1186/s12883-022-02761-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277810/
https://www.ncbi.nlm.nih.gov/pubmed/35820822
http://dx.doi.org/10.1186/s12883-022-02761-8

Ejemplares similares